These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9231990

  • 1. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
    Knolle PA, Eckardt AJ, Protzer-Knolle U, Schirmacher P, Dienes HP, Meyer zum Büschenfelde KH, Gerken G.
    Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
    [Abstract] [Full Text] [Related]

  • 2. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Jun; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 3. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
    Janssen HL, Berk L, de Man RA, Heijtink RA, Schalm SW.
    Ned Tijdschr Geneeskd; 1992 Apr 25; 136(17):835-9. PubMed ID: 1522928
    [Abstract] [Full Text] [Related]

  • 4. [Serum intercellular adhesion molecule ICAM-1 concentration in interferon alpha treated patients with chronic viral C hepatitis].
    Warakomska I, Wiczkowski A, Kepa L, Stolarz W, Wilczek K, Błedowski D, Sobala-Szczygieł B, Oczko-Grzesik B, Dziambor AP, Mossor K.
    Wiad Lek; 2004 Apr 25; 57(11-12):641-6. PubMed ID: 15865242
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Preliminary results of the treatment of patients with chronic active hepatitis (CAH) HBsAg+,HBeAg+ with low oral doses of human interferon-alpha].
    Zielińska W, Paszkiewicz J, Korczak A, Własiuk M, Zółtowska A, Szutowicz J, Cummins J, Georgiades J.
    Przegl Epidemiol; 1991 Apr 25; 45(4):325-30. PubMed ID: 1841411
    [Abstract] [Full Text] [Related]

  • 8. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
    Chrobot A, Chrobot AM, Szaflarska-Szczepanik A.
    Med Sci Monit; 2002 Apr 25; 8(4):CR269-73. PubMed ID: 11951069
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
    Molica S, Levato D, Dell' Olio M, Cascavilla N, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.
    Haematologica; 1997 Apr 25; 82(2):148-51. PubMed ID: 9175316
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 25; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 13. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK.
    J Viral Hepat; 2007 Mar 25; 14(3):169-75. PubMed ID: 17305882
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 25; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 15. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW.
    Hepatology; 1997 Nov 10; 26(5):1338-42. PubMed ID: 9362381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan 10; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.